Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kim, M.-S., Roh, S. W., & Bae, J.-W. (2010a). Bacteroides faecis sp. nov., isolated from human faeces. International Journal of Systematic and Evolutionary Microbiology, 60(Pt 11), 2572–2576.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces
DNA G+C(%): 42.7
|
Opt. T: 37℃
Lower T(℃): 25(+)
Mid T(℃): 43(+)
Bile reaction(%): neg
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
Acetate, Succinate |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
piperacillin: I(64)
piper-taz: S(16)
imipenem: S(0.25)
meropenem: S(0.25)
|
cefotetan: R(256)
cefoxitin: R(64)
|
kanamycin: Res
|
|
moxifloxacin: SensRNG: (1-2)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tigecycline: SensRNG: (0.5-1)
|
|
|
chloramphenicol: S(8)
metronidazole: S(2)
|
clindamycin: SensRNG: (2-4)
|